Bifrost Biosystems Appoints Jonas Jarvius as New CEO and President

Share This Post

Key Highlights

  • Jonas Jarvius, PhD, named CEO, President, and Director of Bifrost Biosystems.
  • Over 15 years of C-level executive experience in life sciences.
  • Expert in commercializing innovative technologies impacting human health.
  • Former CEO of Q-Linea, led company to multinational commercial success.
  • Bifrost’s OPS platform revolutionizes functional genomics and drug discovery.

Source: Business Wire

Notable Quotes

  • “On behalf of our board of directors, we enthusiastically welcome Jonas to his new role as President and CEO of Bifrost and look forward to the many successes ahead for him and the team. Jonas’s strong technical background combined with his demonstrated business acumen will bring a level of rigor and visionary leadership essential to driving Bifrost’s success.” — Shawn Marcell, co-founder and Chairman at Bifrost
  • “I am excited to lead Bifrost and work with such an exceptionally talented team. In my career, I have had the good fortune of developing and commercializing disruptive technologies in protein interaction analysis, rapid Antibiotic Susceptibility Testing and advanced microfluidics. The Bifrost OPS technology is similarly well-positioned to disrupt drug discovery and empower researchers to make better-informed decisions.” — Jonas Jarvius, PhD, named CEO, President, and Director at Bifrost Biosystems

SoHC's Take

The appointment of Dr. Jonas Jarvius as CEO, President, and Director of Bifrost Biosystems marks a strategic move to further solidify the company’s position as a leader in the life sciences sector. With Dr. Jarvius’s extensive experience in translating cutting-edge technologies into commercial successes, Bifrost is well-poised to enhance its innovative OPS platform. His proven track record in driving companies from technological inception to global commercial operations is invaluable. Under his leadership, Bifrost is expected to continue advancing its high-throughput optical pooled screening solutions, ultimately accelerating breakthroughs in drug discovery and functional genomics. This appointment underscores Bifrost’s commitment to leadership that can harness both scientific and business prowess to propel the company forward.

More To Explore

Total
0
Share